Literature DB >> 12000205

Randomized trial of the efficacy of bright-light exposure and aerobic exercise on depressive symptoms and serum lipids.

Sami J Leppämäki1, Timo T Partonen, Jukka Hurme, Jari K Haukka, Jouko K Lönnqvist.   

Abstract

BACKGROUND: Season-related subsyndromal depressive symptoms during winter are common among populations at high latitudes. Both physical exercise and exposure to bright light can relieve the fatigue and downturn of mood associated with the shortening length of day. Serum cholesterol level may be related to changes in mood, but the evidence is contradictory. Our objective was to compare the effect of aerobic exercise with or without bright-light exposure on health-related quality of life, mood, and serum lipids in a sample of relatively healthy adult subjects.
METHOD: A randomized controlled trial was conducted with subjects allocated to group aerobics training in a gym with bright light (2500-4000 lux) (N = 40) or normal illumination (N = 42) or to relaxation/stretching sessions in bright light as a control group (N = 42) twice a week for a period of 8 weeks. Changes in mood were recorded using questionnaires at the beginning of the study, at weeks 4 and 8. and at follow-up 4 months after the study. A blood sample was drawn before and after the 8-week intervention to measure the concentrations of serum lipids.
RESULTS: Ninety-eight subjects completed the 8-week study. Both exercise and bright light effectively relieved depressive symptoms. Bright light reduced atypical depressive symptoms more than exercise (p = .03), based on the atypical symptoms subscore of the Structured Interview Guide for the Hamilton Depression Rating Scale-Seasonal Affective Disorders Version Self-Rating Format. There were no significant differences between the study groups in the changes in serum lipid levels.
CONCLUSION: Bright light administered twice a week, alone or combined with physical exercise, seems to be a useful intervention for relieving seasonal mood slumps.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12000205

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  7 in total

1.  Vitamin D and depression: where is all the sunshine?

Authors:  Sue Penckofer; Joanne Kouba; Mary Byrn; Carol Estwing Ferrans
Journal:  Issues Ment Health Nurs       Date:  2010-06       Impact factor: 1.835

2.  Improvement in Fatigue, Sleepiness, and Health-Related Quality of Life with Bright Light Treatment in Persons with Seasonal Affective Disorder and Subsyndromal SAD.

Authors:  Cecilia Rastad; Jan Ulfberg; Per Lindberg
Journal:  Depress Res Treat       Date:  2011-06-13

3.  Randomized trial of exercise in sedentary middle aged women: effects on quality of life.

Authors:  Deborah J Bowen; Megan D Fesinmeyer; Yutaka Yasui; Shelley Tworoger; Cornelia M Ulrich; Melinda L Irwin; Rebecca E Rudolph; Kristin L LaCroix; Robert R Schwartz; Anne McTiernan
Journal:  Int J Behav Nutr Phys Act       Date:  2006-10-04       Impact factor: 6.457

4.  Indoors illumination and seasonal changes in mood and behavior are associated with the health-related quality of life.

Authors:  Sharon Grimaldi; Timo Partonen; Samuli I Saarni; Arpo Aromaa; Jouko Lönnqvist
Journal:  Health Qual Life Outcomes       Date:  2008-08-01       Impact factor: 3.186

Review 5.  Physical Activity Modulates Common Neuroplasticity Substrates in Major Depressive and Bipolar Disorder.

Authors:  Cristy Phillips
Journal:  Neural Plast       Date:  2017-04-26       Impact factor: 3.599

6.  Association of light exposure on physical activity and sedentary time in young people.

Authors:  Daniel Aggio; Lee Smith; Abigail Fisher; Mark Hamer
Journal:  Int J Environ Res Public Health       Date:  2015-03-10       Impact factor: 3.390

Review 7.  The Long Run: Neuroprotective Effects of Physical Exercise on Adult Neurogenesis from Youth to Old Age.

Authors:  Daniele Saraulli; Marco Costanzi; Valentina Mastrorilli; Stefano Farioli-Vecchioli
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.